<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0008165.ref027">
 <label>27</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Rabaa</surname>
   <given-names>MA</given-names>
  </name>, 
  <name>
   <surname>Girerd-Chambaz</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Duong Thi Hue</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Vu Tuan</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Wills</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Bonaparte</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>van der Vliet</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Langevin</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Cortes</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Zambrano</surname>
   <given-names>B</given-names>
  </name>, 
  <name>
   <surname>Dunod</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Wartel-Tram</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Jackson</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Simmons</surname>
   <given-names>CP</given-names>
  </name>. 
  <article-title>Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy</article-title>. 
  <source>Elife</source>. 
  <year>2017</year>
  <month>9</month>
  <day>5</day>;
  <volume>6</volume> pii: 
  <fpage>e24196</fpage>
  <pub-id pub-id-type="doi">10.7554/eLife.24196</pub-id>
  <?supplied-pmid 28871961?>
  <pub-id pub-id-type="pmid">28871961</pub-id>
 </mixed-citation>
</ref>
